Endotelin-1 involved in MS

A forum to discuss Chronic Cerebrospinal Venous Insufficiency and its relationship to Multiple Sclerosis.
Post Reply
User avatar
Family Elder
Posts: 1494
Joined: Wed Dec 02, 2009 3:00 pm

Endotelin-1 involved in MS

Post by frodo » Sun Nov 24, 2019 5:48 am

Endotelin-1 (ET-1) is a protein related to the vascular system.

Modulation of cytokine-induced astrocytic endothelin-1 production as a possible new approach to the treatment of multiple sclerosis.

https://www.frontiersin.org/articles/10 ... 1/abstract

Results and Conclusions:

ET-1 secretion by astrocytoma cells was only stimulated by the pro-inflammatory cytokines IL-1β and TNF-α. Fluoxetine, simvastatin and resveratrol significantly inhibited this IL-1β- and TNF-α-induced ET-1 production. Simvastatin and resveratrol significantly reduced ET-1 mRNA levels, indicating an effect at the level of transcription.

Fluoxetine significantly reduced endothelin converting enzyme-1 mRNA levels, suggesting and effect at the level of protein-processing. The required concentrations of simvastatin (> 0.1 µM) and resveratrol (> 10 µM) cannot be achieved in humans using pharmacologically accepted doses. Fluoxetine exerted a significant inhibitory effect on ET-1 secretion at a concentration of 5 µM, which is pharmacologically achievable in human brain, but the effect was modest (< 50% suppression) and probably not sufficient to obtain a clinically relevant ET-1 effect.

Our in vitro model can be a useful screening tool in the development of new drugs to suppress astrocytic ET-1 production. The effect of simvastatin was for the most part mediated via the mevalonate pathway, suggesting that this might be an interesting target for further drug development.

Post Reply
  • Similar Topics
    Last post

Return to “Chronic Cerebrospinal Venous Insufficiency (CCSVI)”